Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
09/04/1997 | CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
09/04/1997 | CA2217714A1 Method and prepackaged swabstick for epithelial cancer screening |
09/03/1997 | EP0792931A2 Products and methods for controlling the suppression of the neoplastic phenotype |
09/03/1997 | EP0792157A1 Preparation of mhc-peptide complexes |
09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
09/03/1997 | EP0576521B1 Improvements in or relating to contrast agents |
09/02/1997 | US5663482 Genetic engineering |
09/02/1997 | US5663413 Biphenyl iodinated derivatives and their diagnostic use |
09/02/1997 | US5663301 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
09/02/1997 | US5662885 Peptide derived radionuclide chelators |
09/02/1997 | US5662883 Microprecipitation of micro-nanoparticulate pharmaceutical agents |
09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
08/28/1997 | WO1997031266A1 Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof |
08/28/1997 | WO1997031005A1 Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents |
08/28/1997 | WO1997030969A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
08/28/1997 | WO1997030736A2 Contrast medium |
08/28/1997 | WO1997030735A2 A process for the purification of opacifying contrast agents |
08/28/1997 | WO1997030734A1 Magnetic resonance blood pool agents |
08/28/1997 | WO1997030733A1 Magnetic resonance blood pool agents bound to human serum albumin |
08/28/1997 | DE19608278A1 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie Pharmaceutical preparations containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and radiology interventioniellen |
08/28/1997 | DE19606207A1 Verfahren zur Bestimmung der Phototoxizität und/oder Photosensibilität von Stoffen oder Stoffgemischen sowie dessen Verwendung Method for determining the phototoxicity and / or photosensitivity of substances or mixtures of substances and its use |
08/28/1997 | CA2247253A1 Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumour therapy and interventional radiology |
08/28/1997 | CA2247244A1 Magnetic resonance blood pool agents bound to human serum albumin |
08/28/1997 | CA2247192A1 Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof |
08/28/1997 | CA2247041A1 Contrast medium |
08/27/1997 | EP0791361A2 Method, apparatus, and medicine for clogging blood vessels of eye fundus |
08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
08/27/1997 | EP0702793A4 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
08/27/1997 | EP0698119A4 Rapid diagnostic procedure for ivermectin resistance |
08/27/1997 | EP0653063A4 In vitro test for dermal corrosive properties. |
08/27/1997 | EP0563179B1 Vascular catheter having low-profile distal end |
08/27/1997 | CN1158133A Peptide derived radionuclide chelators |
08/27/1997 | CN1158082A Container with multi-phase composition for use in diagnostic and therapeutic applications |
08/26/1997 | US5660827 Antibodies that bind to endoglin |
08/26/1997 | US5660822 Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use |
08/26/1997 | US5660815 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents |
08/26/1997 | US5660814 Iodinated paramagnetic chelates, and their use as contrast agents |
08/21/1997 | WO1997030174A1 Combinations of pkc inhibitors and therapeutic agents for treating cancers |
08/21/1997 | WO1997030108A1 Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins |
08/21/1997 | WO1997029836A1 Apparatus and method for producing polarised vapour-phase helium-3, particularly for nmr imaging |
08/21/1997 | WO1997029785A1 Diagnostic agent for digestive diseases |
08/21/1997 | WO1997029783A1 Improvements in or relating to contrast agents |
08/21/1997 | WO1997029782A1 Thermally stabilized contrast agent |
08/21/1997 | DE19606223A1 Kit for epicutaneous tests for determination of allergens such as dental amalgam |
08/21/1997 | CA2246778A1 Thermally stabilized contrast agent |
08/21/1997 | CA2246734A1 Combinations of pkc inhibitors and therapeutic agents for treating cancers |
08/21/1997 | CA2246665A1 Diagnostic agent for digestive diseases |
08/20/1997 | EP0789783A1 Antigen binding peptides (abtides) from peptide libraries |
08/20/1997 | EP0789594A1 Use of additives in contrast mediums to improve imaging |
08/20/1997 | EP0593446B1 Monoclonal antibody which distinguishes helper inducer and supressor inducer cd4+ lymphocytes |
08/20/1997 | CN1157573A Improvement in or relating to contrast agents |
08/20/1997 | CN1035661C Low-density contrast medium |
08/19/1997 | US5658962 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
08/19/1997 | US5658880 Prevent selectin binding; antiinflammatory, anticancer agents; aids therapy |
08/19/1997 | US5658741 Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation |
08/19/1997 | US5658551 Stable microbubbles suspensions injectable into living organisms |
08/19/1997 | US5658550 Non cross-linked synthetic polymers as contrast media for magnetic resonance imaging |
08/19/1997 | CA1339340C Method for tumor detection and treatment |
08/18/1997 | EP1011415A4 Non-invasive method for diagnosing alzheimer's disease in a patient |
08/14/1997 | WO1997029128A1 GPIb-LIPID COMPLEX AND USES THEREOF |
08/14/1997 | WO1997029114A1 Biotin-containing compounds, biotinylation reagents and methods |
08/14/1997 | WO1997014679A3 Method of detecting cyclooxygenase-2 |
08/14/1997 | WO1997005904A3 Use of metal clusters as a contrast or radiotherapy agent |
08/14/1997 | DE19604484A1 Operation fields in living beings are long term stained |
08/13/1997 | EP0788376A2 Calixarene conjugates useful as mri and ct diagnostic imaging agents |
08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
08/13/1997 | EP0788348A1 Container with multi-phase composition for use in diagnostic and therapeutic applications |
08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
08/13/1997 | EP0638064B1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer |
08/13/1997 | EP0558663B1 Drug delivery porphyrin compositions and methods |
08/13/1997 | EP0458937B1 Variants of pai-2 |
08/13/1997 | CN1156626A Dextran albumin acoustical contrast medium containing perfluocarbon and its producing process |
08/12/1997 | US5656651 Androgenic directed compositions |
08/12/1997 | US5656600 Modified polypeptides |
08/12/1997 | US5656211 Apparatus and method for making gas-filled vesicles of optimal size |
08/07/1997 | WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use |
08/07/1997 | WO1997028250A1 Androgen-repressed metastatic human prostate cancer cell line |
08/07/1997 | WO1997027888A1 Methods for embolizing blood vessels |
08/07/1997 | WO1997027801A1 Laser opto-acoustic imaging system |
08/07/1997 | WO1997027745A1 Method of diagnosis and treatment and related compositions and apparatus |
08/07/1997 | WO1997004811A3 Use of liposomal preparations in indirect mri lymphography |
08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
08/07/1997 | CA2244889A1 Androgen-repressed metastatic human prostate cancer cell line |
08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
08/06/1997 | EP0787017A1 Diagnostic preparation for detection of helicobacter pylori |
08/06/1997 | EP0664819B1 Chelating polymers |
08/06/1997 | EP0525181B1 Novel lanthanide chelate-conjugated oligonucleotides |
08/06/1997 | CN1156442A Dimer DTPA derivatives and their metal complexes, pharmaceuticals containing the same, the use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
08/06/1997 | CN1035542C Method for preparing contrast media |
08/05/1997 | US5654452 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions |
08/05/1997 | US5654413 Oligonucleotide tags for specific hybridization |
08/05/1997 | US5654195 Vectors expressing hybrid viruses, methods of use and novel assays |
08/05/1997 | US5654160 Imine- and mercaptan-containing aryl ligands; quantitative analysis; immunoassay; detecting metal concentrations in blood samples |
08/05/1997 | US5653960 Tetra-aza macrocycles, processes for their preparation and their use in magnetic resonance imaging |
08/05/1997 | US5653959 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
08/05/1997 | US5653693 Obtained by molding propylene resin composition and phosphoric ester nucleating agent; syringe is prefilled with drug |
08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
07/31/1997 | WO1997027462A2 Use of peptides in tracing disease and developing vaccines |